Avelas Biosciences Secures $7,650,000 Series A Funding

  • Feed Type
  • Date
    12/7/2012
  • Company Name
    Avelas Biosciences
  • Mailing Address
    11099 N. Torrey Pines Road La Jolla, CA 92037
  • Company Description
    At Avelas Biosciences, our mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.
  • Website
    http://www.avelasbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,650,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Avelas will use the funding to advance the Avelas Cancer Illuminator (ACI) towards clinical studies for the visualization of cancerous lymph nodes in breast cancer patients.
  • M&A Terms
  • Venture Investor
    Avalon Ventures

By posting a comment, you agree to our terms and conditions.